Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center

Journal of Thoracic Oncology

Volumn 3, Issue 11, 2008, Pages 1332-1341

  Dahele, Max ^a,b   Pearson, Shannon ^a   Purdie, Tom ^a,b   Bissonnette, Jean Pierre ^a,b   Franks, Kevin ^c   Brade, Anthony ^a,b   Cho, John ^a,b   Sun, Alex ^a,b   Hope, Andrew ^a,b   Marshall, Andrea ^a   Higgins, Jane ^a,b   Bezjak, Andrea ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Clinical process; Lung cancer; Quality assurance; Stereotactic body radiation therapy

Indexed keywords

ARTICLE; CANCER CENTER; CANCER RISK; CELL HETEROGENEITY; FOLLOW UP; HUMAN; IRRADIATION; LUNG CANCER; LUNG DEVELOPMENT; LUNG DIFFUSION; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TUMOR VOLUME; CANCER STAGING; HEALTH CARE QUALITY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PATHOLOGY; RADIOSURGERY;

CANCER CARE FACILITIES; CARCINOMA, NON-SMALL-CELL LUNG; GUIDELINES AS TOPIC; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; RADIOSURGERY;

EID: 58949089102     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31818b1771     Document Type: Article

References (45)

1. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-319.
2. Blomgren H, Lax I, Naslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34: 861-870.
3. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998;82:1062-1070.
4. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955.
5. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998;40: 149-154.
6. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94-S100.
7. Hoyer M, Roed H, Traberg Hansen A, et al. Phase II study on stereo-tactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45: 823-830.
8. Hiraoka M, Matsuo Y, Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiother 2007;11:32-35.
9. Senan S, Haasbeek NJ, Smit EF, Lagerwaard FJ. Stereotactic radiotherapy for centrally located early-stage lung tumors. J Clin Oncol 2007; 25:464.
10. Fowler JF, Tomé WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60:1241- 1256. Erratum in: Int J Radiat Oncol Biol Phys 2005;61:962.
11. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-4839.
12. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787-795.
13. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-135.
14. Yamashita H, Nakagawa K, Nakamura N, et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereo-tactic radiation therapy for lung tumors. Radiat Oncol 2007;2:21.
15. Matsuo Y, Takayama K, Nagata Y, et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2007;68:416-425.
16. Bradley J. Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol 2007;2:S118 - S124.
17. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2007;2:S101 - S112.
18. Chang JY, Roth JA. Stereotactic body radiation therapy for stage I non-small cell lung cancer. Thorac Surg Clin 2007;17:251-259.
19. Timmerman R, Galvin J, Michalski J, et al. Accreditation and quality assurance for radiation therapy oncology group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol 2006;45:779-786.
20. Underberg RW, Lagerwaard FJ, Cuijpers JP, et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys 2004;60:1283-1290.
21. Purdie TG, Bissonnette JP, Franks K, et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 2007;68:243-252.
22. Ball D, Withers HR. Stereotactic radiotherapy for stage I non-small-cell lung cancer-the triumph of technology over biology? Nat Clin Pract Oncol 2007;4:614-615.
23. Murray B, Forster K, Timmerman R. Frame-based immobilization and targeting for stereotactic body radiation therapy. Med Dosim 2007;32: 86-91.
24. Purdie TG, Moseley DJ, Bissonnette JP, et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in stereotactic lung radiation therapy. Acta Oncol 2006;45:915-922.
25. Franks KN, Purdie TG, Bezjak A, et al. Quantifying Inter and Intra-Fraction Tumor Motion using Respiration-Correlated Cone Beam CT in Lung Stereotactic Body Radiotherapy (SBRT). Int J Radiat Oncol Biol Phys 2007;69:S489-S490.
26. Grills IS, Fitch DL, Goldstein NS, et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:334 -341.
27. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 2005;62:554-560.
28. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-692.
29. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196.
30. Joyner M, Salter BJ, Papanikolaou N, et al. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 2006;45:802-807.
31. Song DY, Benedict SH, Cardinale RM, et al. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 2005;28: 591-596.
32. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive Analysis of Oligometastatic Lesions Treated with Curative-Intent Ste-reotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys 2008; (Epub ahead of print).
33. Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006;45:856-864.
34. Kavanagh BD, Schefter TE, Cardenes HR, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006;45:848-855.
35. Chang D, Liu C, Dempsey JF, et al. Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. Am J Clin Oncol 2007;30:57-62.
36. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology; American College of Radiology. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004;60:1026-1032.
37. Bissonnette JP. Quality assurance of image-guidance technologies. Semin Radiat Oncol 2007;17:278-286.
38. Sharpe MB, Moseley DJ, Purdie TG, et al. The stability of mechanical calibration for a kV cone beam computed tomography system integrated with linear accelerator. Med Phys 2006;33:136-144.
39. Salazar OM, Sandhu TS, Lattin PB, et al. Once-weekly, high-dose stereotactic body radiotherapy for lung v: 6-Year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers. Int J Radiat Oncol Biol Phys 2008; (Epub ahead of print).
40. Jin JY, Ajlouni M, Ryu S, et al. A technique of quantitatively monitoring both respiratory and nonrespiratory motion in patients using external body markers. Med Phys 2007;34:2875-2881.
41. Hugo G, Vargas C, Liang J, et al. Changes in the respiratory pattern during radiotherapy for cancer in the lung. Radiother Oncol 2006;78: 326-331.
42. Timmerman R, Abdulrahman R, Kavanagh BD, Meyer JL. Lung cancer: a model for implementing stereotactic body radiation therapy into practice. Front Radiat Ther Oncol 2007;40:368-385.
43. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofraction-ated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006;45:796-801.
44. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008;70:1057-1065.
45. Massoud MR, Nielsen GA, Nolan K, et al. (Eds.) A Framework for Spread: From Local Improvements to System-Wide Change. IHI Innovation Series white paper. Cambridge, MA: Institute for Healthcare Improvement; 2006.